|
1
|
Wong RS and Cheong SK: Leukaemic stem
cells: Drug resistance, metastasis and therapeutic implications.
Malays J Pathol. 34:77–88. 2012.PubMed/NCBI
|
|
2
|
Raetz EA and Bhatla T: Where do we stand
in the treatment of relapsed acute lymphoblastic leukemia?
Hematology Am Soc Hematol Educ Program. 2012:129–136.
2012.PubMed/NCBI
|
|
3
|
Bianco P, Cao X, Frenette PS, Mao JJ,
Robey PG, Simmons PJ and Wang CY: The meaning, the sense and the
significance: Translating the science of mesenchymal stem cells
into medicine. Nat Med. 19:35–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meads MB, Hazlehurst LA and Dalton WS: The
bone marrow microenvironment as a tumor sanctuary and contributor
to drug resistance. Clin Cancer Res. 14:2519–2526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong RY and Cheong SK: Role of mesenchymal
stem cells in leukaemia: Dr. Jekyll or Mr. Hyde? Clin Exp Med.
14:235–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mudry RE, Fortney JE, York T, Hall BM and
Gibson LF: Stromal cells regulate survival of B-lineage leukemic
cells during chemotherapy. Blood. 96:1926–1932. 2000.PubMed/NCBI
|
|
7
|
Dias S, Choy M, Alitalo K and Rafii S:
Vascular endothelial growth factor (VEGF)-C signaling through FLT-4
(VEGFR-3) mediates leukemic cell proliferation, survival, and
resistance to chemotherapy. Blood. 99:2179–2184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Benabbou N, Mirshahi P, Bordu C, Faussat
AM, Tang R, Therwath A, Soria J, Marie JP and Mirshahi M: A subset
of bone marrow stromal cells regulate ATP-binding cassette gene
expression via insulin-like growth factor-I in a leukemia cell
line. Int J Oncol. 45:1372–1380. 2014.PubMed/NCBI
|
|
9
|
Record M, Subra C, Silvente-Poirot S and
Poirot M: Exosomes as intercellular signalosomes and
pharmacological effectors. Biochem Pharmacol. 81:1171–1182. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vlassov AV, Magdaleno S, Setterquist R and
Conrad R: Exosomes: Current knowledge of their composition,
biological functions, and diagnostic and therapeutic potentials.
Biochim Biophys Acta. 1820:940–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai RC, Arslan F, Lee MM, Sze NS, Choo A,
Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, et al:
Exosome secreted by MSC reduces myocardial ischemia/reperfusion
injury. Stem Cell Res. 4:214–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huan J, Hornick NI, Shurtleff MJ, Skinner
AM, Goloviznina NA, Roberts CT Jr and Kurre P: RNA trafficking by
acute myelogenous leukemia exosomes. Cancer Res. 73:918–929. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Umezu T, Ohyashiki K, Kuroda M and
Ohyashiki JH: Leukemia cell to endothelial cell communication via
exosomal miRNAs. Oncogene. 32:2747–2755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Raimondo S, Saieva L, Corrado C, Fontana
S, Flugy A, Rizzo A, De Leo G and Alessandro R: Chronic myeloid
leukemia-derived exosomes promote tumor growth through an autocrine
mechanism. Cell Commun Signal. 13:82015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ansa-Addo EA, Lange S, Stratton D,
Antwi-Baffour S, Cestari I, Ramirez MI, McCrossan MV and Inal JM:
Human plasma membrane-derived vesicles halt proliferation and
induce differentiation of THP-1 acute monocytic leukemia cells. J
Immunol. 185:5236–5246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roccaro AM, Sacco A, Maiso P, Azab AK, Tai
YT, Reagan M, Azab F, Flores LM, Campigotto F, Weller E, et al: BM
mesenchymal stromal cell-derived exosomes facilitate multiple
myeloma progression. J Clin Invest. 123:1542–1555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mineo M, Garfield SH, Taverna S, Flugy A,
De Leo G, Alessandro R and Kohn EC: Exosomes released by K562
chronic myeloid leukemia cells promote angiogenesis in a
Src-dependent fashion. Angiogenesis. 15:33–45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tadokoro H, Umezu T, Ohyashiki K, Hirano T
and Ohyashiki JH: Exosomes derived from hypoxic leukemia cells
enhance tube formation in endothelial cells. J Biol Chem.
288:34343–34351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reiners KS, Topolar D, Henke A, Simhadri
VR, Kessler J, Sauer M, Bessler M, Hansen HP, Tawadros S, Herling
M, et al: Soluble ligands for NK cell receptors promote evasion of
chronic lymphocytic leukemia cells from NK cell anti-tumor
activity. Blood. 121:3658–3665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen W, Wang J, Shao C, Liu S, Yu Y, Wang
Q and Cao X: Efficient induction of antitumor T cell immunity by
exosomes derived from heat-shocked lymphoma cells. Eur J Immunol.
36:1598–1607. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fortney JE, Zhao W, Wenger SL and Gibson
LF: Bone marrow stromal cells regulate caspase 3 activity in
leukemic cells during chemotherapy. Leuk Res. 25:901–907. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hall BM, Fortney JE, Taylor L, Wood H,
Wang L, Adams S, Davis S and Gibson LF: Stromal cells expressing
elevated VCAM-1 enhance survival of B lineage tumor cells. Cancer
Lett. 207:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Camussi G, Deregibus MC, Bruno S, Grange
C, Fonsato V and Tetta C: Exosome/microvesicle-mediated epigenetic
reprogramming of cells. Am J Cancer Res. 1:98–110. 2011.PubMed/NCBI
|
|
24
|
Fodale V, Pierobon M, Liotta L and
Petricoin E: Mechanism of cell adaptation: When and how do cancer
cells develop chemoresistance? Cancer J. 17:89–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zaman S, Wang R and Gandhi V: Targeting
the apoptosis pathway in hematologic malignancies. Leuk Lymphoma.
55:1980–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Delbridge AR and Strasser A: The BCL-2
protein family, BH3-mimetics and cancer therapy. Cell Death Differ.
22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reed JC: Bcl-2-family proteins and
hematologic malignancies: History and future prospects. Blood.
111:3322–3330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yi CH and Yuan J: The Jekyll and Hyde
functions of caspases. Dev Cell. 16:21–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai P: Biology of poly(ADP-Ribose)
polymerases: The factotums of cell maintenance. Mol Cell.
58:947–958. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Hendrix A, Hernot S, Lemaire M, De
Bruyne E, Van Valckenborgh E, Lahoutte T, De Wever O, Vanderkerken
K and Menu E: Bone marrow stromal cell-derived exosomes as
communicators in drug resistance in multiple myeloma cells. Blood.
124:555–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
